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DOI 10.1016/j.chembiol.2008.01.002We live in a world dominated by microbial
life, and nomatter how hard we try and rid
them from our lives with germicides, ultra-
violet light, or radiation, there is noescape.
In fact, each square centimeter of our
bodies is host to approximately 100,000
microorganisms. They are found in every
possible niche on our planet including
the most extreme locations such as the
Atacama Desert in Peru or the Dry Valleys
of Antarctica. They can thrive under salty
or acidic conditions, even living in solid
ice. Some species of bacteria such as
Deinococcus radiodurans have even been
found thriving inside nuclear reactors and
can survive 50 kGy of g radiation. This is
ten times the dose that kills most otherGlobally, one of the largest problems facing the health care indus-
try today is that hospital-acquired infections (HAI) are on the rise.microbes. Deep inside the Earth, microor-
ganisms are found at depths of more than
4km,and the number of them living under-
ground has been estimated to be over 100
trillion tons.
For humans, one of the most important
facts about microorganisms is that many
of them are disease causing. Although
many of the diseases caused bymicrobes
can be successfully treated nowadays,
there is new trouble on the horizon. Glob-
ally, one of the largest problems facing the
health care industry today is that hospital-
acquired infections (HAI) are on the rise.
In 2007, de Zoysa andMorecroft reported
that HAI cost the United Kingdom over
$2 billion and affected 10,000 patients,
of which 5,000 did not survive (de Zoysa
andMorecroft, 2007). In theUnited States,
the situation is no better. In 2002, a
report published by the Centers for Dis-
ease Control and Prevention estimated
that 1.7 million people acquired HAI and
98,987 people died as a consequence
(http://www.cdc.gov/nchs/). The frighten-ing breakdown has 32% of all HAI as
urinary tract infections, 22% as surgical
site infections, 15% as lung infections
(pneumonia), and the remaining 14% at-
tributed to bloodstream infections. Most
recently, fears over the highly conta-
gious,methicillin-resistantStaphylococcus
aureus (MRSA) bacteria have increased,
when a report was published showing
that MRSA is spread not only by contact
with infected surfaces, but is also airborne
(Huws et al., 2006). This has prompted
a renewed interest in microbial surveil-
lance in hospitals.
Another source of dangerous microbes
is the pharmaceutical industry. Although
rare, massive recalls can occur due to mi-crobial contamination whichmay threaten
lives. On December 14, 2007, the Ameri-
can Pharmaceutical firm Merck & Co.,
Inc., West Point, Pennsylvania, recalled
1.2 million doses of a children’s vaccine
headed for China. The vaccine, known
as PedvaxHIB, was intended for use in
protecting against Haemophilus influen-
zae type b, the leading cause of bacterial
meningitis in young children. Quality con-
trol technicians at Merck had discovered
that some of their equipment was improp-
erly sterilized and initiated the recall
(CDC, 2007).
Both the pharmaceutical and health-
care industrieshavemicrobial surveillance
guidelines published by the United Stated
Food and Drug Administration and Cen-
ters for Disease Control and Prevention
(Siegel et al., 2007). These guidelines
maintain that a ‘‘clean room’’ environment
must be kept for limiting biocontamination
through the use of monitoring and surveil-
lancemethods, sterilizing germicides, and
air filters, as well as training workers toChemistry & Biology 15, January 20follow strict protocols that minimize con-
tact with the outside, germ-filled world.
Essentially, clean rooms are places where
the dust, particles, and microbes found
floating in the air are restricted by the use
of extensive filtering systems. The air we
breathe in our homes and offices can
contain from 2 to 10 million particles per
cubic foot. Clean rooms are divided into
various classes depending on the number
of particles (0.5 mm in size) in a cubic foot
of room air. For example, a class 100,000
clean room can have no more than
100,000 0.5 mm particles in a cubic foot
of air, whereas a class 100 clean room is
limited to only 100 particles. Hospital op-
erating rooms are considered to be class
10,000 clean rooms. The pharmaceutical
industry typically uses a class 100 clean
room.Modified ATP Surveillance
in Spacecraft Clean Rooms
NASAplanetaryprotectionprotocolswere
established by the United Nations in 1967
to insure that outgoing spacecraft do
not contaminate the celestial bodies they
land on with terrestrial microbes (United
Nations, 1967). In keeping with this prac-
tice, NASA’s spacecraft assembly clean
room facilities are very unique eco-
logical niches that have some of the low-
est diversity of microbial species present
per square meter; that being said, they
still contain microbes. NASA clean rooms
are rated between class 10 and 100. Until
recently, the standard procedure was to
take microbial assessments from vari-
ous spacecraft hardware and parts, using
standard culture methods to make sure
that the total bioburden doesn’t exceed
3 3 105 spores. The same microbial sur-
veillance method is used widely today by
both the health care and pharmaceutical
industry. According to Robert Lodder, a
professor of pharmaceutical sciences at
the University of Kentucky, ‘‘inoculating
media, growing cultures and smearing08 ª2008 Elsevier Ltd All rights reserved 1
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pharmaceutical industry is very conserva-
tive, and justifiably so. They really do not
kill many people with sterility problems
using their existing techniques, so they
are reluctant to change.’’ Culture-based
methods are typified by wiping surfaces
with sterile moist swabs or wipes, placing
them intodishescontainingnutrientmedia,
and then incubating aerobically at 32C for
several days. By that time, a serious con-
tamination event may already be under-
way. Another problem is that most clean
rooms and operating rooms contain a
wide variety of microorganisms, with each
one requiring a different nutrient media
to grow in. Some previous studies have
shown that only 10% of clean room sam-
ples were able to grow in a specific culture
medium, so how can there be any reliable
certainty of how many microbes there are
in these facilities?
In a recently published report by Moissl
and colleagues (Moissl et al., 2007), the
authors modified and used a portable
adenosine triphosphate (ATP) surveil-
lance kit to rapidly identify microbial con-
tamination in threeNASA spacecraft clean
rooms. The study found that there are far
more microbes in their clean rooms than
have previously been detected using cul-
ture-based methods, raising the issue of
the level of cleanliness in other facilities
in the pharmaceutical and healthcare in-
dustries. The method used in the study
was so efficient that when the samples
were later examined with DNA extraction
polymerase chain reaction (PCR) and the
genes sequenced, 45% of the microor-
ganisms found were previously unknown
to science. Furthermore, the modified ATP
test provides an accurate measurement
of intracellular ATP found in viable living
cells in about 30 s. ATP is a molecule
found in all living and dead cells. In living
cells, it is found intracellularly, and in
dead cells, extracellularly. Although ATP
detectors have been in use since the early
1960s to evaluate industrial hygiene qual-
ity, results usually take 24–72 hr.2 Chemistry & Biology 15, January 2008 ª20The new, modified ATP kit used in the
study by Moissl et al. was developed in
collaboration between the Kikkoman Cor-
poration in Noda City, Japan, and NASA’s
Jet Propulsion Laboratory in Pasadena,
California. Kasthuri Venkateswaran, who
is a microbiologist in the Biotechnology
and Planetary Protection Group within
NASA’s Jet Propulsion Laboratory and
one of the lead authors on the Moissl
et al. paper and instrumental in modifying
Kikkoman’s ATP detector for making
quick assays in spacecraft clean rooms,
says, ‘‘Our work has great influence on
pharmaceutical and medical industries
since these are health-oriented indus-
tries.’’ The modified ATP detection is
based on bioluminescence and uses the
chemical enzyme luciferase, the same
chemical that makes a firefly’s glow. The
luciferase is obtained by growing geneti-
cally engineered bacteria that produce
it in the laboratory. Lodder, meanwhile,
says, ‘‘In their paper, the authors are cor-
rect in suggesting that culture-based
methods can be something of an art form
and that it can be difficult to get species
to grow. Their modified ATP assay would
likely find more species than the culture-
basedmethod in spacecraft clean rooms.’’
Venkateswaran’s enhancement of Kik-
koman’s ATP kit was accomplished by
genetically engineering luciferase to with-
stand high pH conditions, allowing the
ATP from any dead microbes to be mea-
sured and giving a total microbial esti-
mate. ‘‘To determine the total ATP, a user
takes a sterile cotton swab, rubbing it
over an area to be sampled. A sample is
combined with benzalkonium chloride (a
detergent) for lysing the cells so that all
the microbial ATP can be released. It is
then briefly incubated at room tempera-
ture and the luciferin-luciferase is added,’’
explains Venkateswaran. The ATP then
combines with the luciferase and begins
to glow. A photon counter called a lumin-
ometer detects the number of photons
proportional to the amount of ATP in the
sample, and a result is rendered for both08 Elsevier Ltd All rights reservedliving and dead cells in about 30 min.
The sensitivity of the modified ATP test
is about 100 cells per sample at present.
Venkateswaran thinks he will eventually
get the sensitivity down to the light gener-
ated by only one cell. The ATP assay kit is
nowcommerciallyavailable fromKikkoman
Corporation, San Francisco, California.
Meanwhile, Robert Lodder has his
doubts about the practicality of using
such a sensitive microbial detection de-
vice: ‘‘I doubt that we will ever achieve
a 100%sterile clean room, in part because
it would be so difficult to prove it was ster-
ile. There is something like the Heisenberg
Uncertainty Principle at work, in which the
act of measuring disturbs the result, and
you are never sure where the contamina-
tion occurred or when.’’REFERENCES
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